| Title: | Sex-specific Mendelian randomization study of genetically predicted insulin and cardiovascular events in the UK Biobank |
| Journal: | Communications Biology |
| Published: | 5 Sep 2019 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/31508506/ |
| DOI: | https://doi.org/10.1038/s42003-019-0579-z |
| URL: | https://www.nature.com/articles/s42003-019-0579-z.pdf |
| Citations: | 22 (3 in last 2 years) as of 8 Aug 2024 |
Publication 5734
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Insulin drives growth and reproduction which trade-off against longevity. Genetically predicted insulin, i.e., insulin proxied by genetic variants, is positively associated with ischemic heart disease, but sex differences are unclear, despite different disease rates and reproductive strategies by sex. We used Mendelian randomization in 392,010 white British from the UK Biobank to assess the sex-specific role of genetically predicted insulin in myocardial infarction (MI) (14,442 cases, 77% men), angina (21,939 cases, 65% men) and heart failure (5537 cases, 71% men). Genetically predicted insulin was associated with MI (odds ratio (OR) 4.27 per pmol/L higher insulin, 95% confidence interval (CI) 1.60 to 11.3) and angina (OR 2.93, 1.27 to 6.73) in men, but not women (MI OR 0.80, 95% CI 0.23 to 2.84, angina OR 1.10, 95% CI 0.38 to 3.18). Patterns were similar for insulin resistance and heart failure. Mitigating the effects of insulin might address sexual disparities in health.</p>
3 Authors
- Jie V. Zhao
- Shan Luo
- C. Mary Schooling
Enabling scientific discoveries that improve human health